Targeted silencing of TEM8 suppresses non-small cell lung cancer tumor growth via the ERK/Bcl-2 signaling pathway

Non-small cell lung cancer (NSCLC) is one of the most common malignancies with high rates of mortality. Although great progress has been made with the development of novel immunotherapies and targeted therapeutic strategies, the 5-year total survival rate of lung cancer has remained unchanged over t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Quan, Deng, Jing, Zhang, Lijuan, Zhou, Chunyan, Fu, Chaojiang, Wang, Xicai, Zhuang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240451/
https://www.ncbi.nlm.nih.gov/pubmed/34165155
http://dx.doi.org/10.3892/mmr.2021.12234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240451/
https://www.ncbi.nlm.nih.gov/pubmed/34165155
http://dx.doi.org/10.3892/mmr.2021.12234

Ejemplares similares